Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Barnes

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Respiratory Medicine|March 3, 2009
Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trialC F Ramsay, P Sullivan, M Gizycki, et al.
The European Respiratory Journal|August 21, 2001
The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthmaO M Kon, B S Sihra, L C Loh, et al.
Cellular Immunology|March 24, 1999
Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responsesM S Lebowitz, S M O'Herrin, A R Hamad, et al.
Thorax|February 1, 1996
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosisN Al Jarad, P Demertzis, D J Jones, et al.
Lancet (London, England)|August 11, 2001
Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging studyC H Compton, J Gubb, R Nieman, et al.
BMJ (Clinical Research Ed.)|August 15, 1992
Respiratory medicine: fighting for survivalD P Dhillon, J Winter, M D Morgan, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 1995
Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthmaL M Kuitert, R M Angus, N C Barnes, et al.
The European Respiratory Journal|February 3, 2006
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study designE Gamble, Y Qiu, D Wang, et al.
The European Respiratory Journal|May 17, 2007
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysisE Gamble, D C Grootendorst, K Hattotuwa, et al.
The Journal of Allergy and Clinical Immunology|January 12, 2000
Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skinA J Macfarlane, O M Kon, S J Smith, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Respiratory Medicine|March 3, 2009
Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trialC F Ramsay, P Sullivan, M Gizycki, et al.
The European Respiratory Journal|August 21, 2001
The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthmaO M Kon, B S Sihra, L C Loh, et al.
Cellular Immunology|March 24, 1999
Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responsesM S Lebowitz, S M O'Herrin, A R Hamad, et al.
Thorax|February 1, 1996
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosisN Al Jarad, P Demertzis, D J Jones, et al.
Lancet (London, England)|August 11, 2001
Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging studyC H Compton, J Gubb, R Nieman, et al.
BMJ (Clinical Research Ed.)|August 15, 1992
Respiratory medicine: fighting for survivalD P Dhillon, J Winter, M D Morgan, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 1995
Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthmaL M Kuitert, R M Angus, N C Barnes, et al.
The European Respiratory Journal|February 3, 2006
Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study designE Gamble, Y Qiu, D Wang, et al.
The European Respiratory Journal|May 17, 2007
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysisE Gamble, D C Grootendorst, K Hattotuwa, et al.
The Journal of Allergy and Clinical Immunology|January 12, 2000
Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skinA J Macfarlane, O M Kon, S J Smith, et al.
Pageof 10